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Background
Oral immunotherapy (OIT) for food allergy has shown
promising efficacy results. However, safety is still con-
cerning. Objectives. To evaluate safety of egg-OIT. To
identify clinical/immunological predictors of adverse
events.
Methods
Prospective longitudinal epidemiological intervention
study. Egg-allergic children aged 5–18 underwent a Span-
ish-approved egg-OIT protocol without premedication.
Clinical data, skin prick test (SPT) and specific IgE
(sIgE) at baseline and 9 months after OIT were regis-
tered. All dose-related reactions, treatments needed and
cofactors involved were recorded. Through survival ana-
lysis, we studied the cumulative probability of reactions
resolution over time and clinical/immunological risk fac-
tors of reactions persistence.
Results
51 children were recruited. Mean follow-up was 16
months. 74% reached desensitization to one raw egg.
90% of children suffered reactions, 88% of which
affected a single organ. Reactions occurred in 7% of
doses, being mainly grade 1 (30%) or 2 (32%). Gastroin-
testinal (37%) and cutaneous (35%) were the most fre-
quent symptoms. Reactions were heterogeneously
distributed: (a) 23 children (45%) had occasional symp-
toms which ceased over time; (b) 28 (65%) children had
more frequent and intense symptoms (71% of total reac-
tions). 11 of them, the most difficult cases, had to inter-
rupt the treatment early, whereas in 17 children
reactions decreased in frequency but persisted over-
time. Reactions persistence was associated with a higher
frequency and severity. Kaplan–Meier estimate revealed
a cumulative probability of reactions resolution of 25%
at 6 months (95% CI: 2.95-9.05) and 50% (95% CI: 7.2-
18.8) at 13 months. Cox proportional hazards multivari-
ate regression model identified 2 variables (egg white-
sIgE and Sampson’s severity grades 3 or 4 at baseline
egg challenge) as independent risk factors of reactions
persistence, with hazard ratios of 1.15 (95% CI: 1.05-
1.27; p=0.002) and 4.39 (95% CI: 1.78–10.87; p=0.01),
respectively. Early withdrawal was associated to pre-
existing asthma and higher sIgE levels (p<0.05).
Conclusion
OIT with raw egg white led to early withdrawal due to
adverse events in 21% of children. An additional 33% had
persistent reactions over follow-up. Egg white-sIgE, reac-
tion severity at baseline challenge and pre-existing asthma
would help clinicians to identify highly reactive patients
before egg-OIT. Further research is needed to improve
safety before egg-OIT can be extended to routine practice.
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